SOLTF
Price
$6.15
Change
+$0.05 (+0.82%)
Updated
Jul 25 closing price
Capitalization
538.6M
XTLB
Price
$1.75
Change
-$0.00 (-0.00%)
Updated
Jul 25 closing price
Capitalization
15.64M
Interact to see
Advertisement

SOLTF vs XTLB

Header iconSOLTF vs XTLB Comparison
Open Charts SOLTF vs XTLBBanner chart's image
Nxera Pharma
Price$6.15
Change+$0.05 (+0.82%)
Volume$2.1K
Capitalization538.6M
XTL Biopharmaceuticals
Price$1.75
Change-$0.00 (-0.00%)
Volume$26.58K
Capitalization15.64M
SOLTF vs XTLB Comparison Chart in %
Loading...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SOLTF vs. XTLB commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOLTF is a Hold and XTLB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (SOLTF: $6.15 vs. XTLB: $1.75)
Brand notoriety: SOLTF and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SOLTF: 309% vs. XTLB: 62%
Market capitalization -- SOLTF: $538.6M vs. XTLB: $15.64M
SOLTF [@Biotechnology] is valued at $538.6M. XTLB’s [@Biotechnology] market capitalization is $15.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SOLTF’s FA Score shows that 0 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • SOLTF’s FA Score: 0 green, 5 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, XTLB is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 4 TA indicator(s) are bullish while XTLB’s TA Score has 6 bullish TA indicator(s).

  • SOLTF’s TA Score: 4 bullish, 5 bearish.
  • XTLB’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, XTLB is a better buy in the short-term than SOLTF.

Price Growth

SOLTF (@Biotechnology) experienced а +8.08% price change this week, while XTLB (@Biotechnology) price change was -0.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($539M) has a higher market cap than XTLB($15.6M). SOLTF YTD gains are higher at: -0.122 vs. XTLB (-13.614).
SOLTFXTLBSOLTF / XTLB
Capitalization539M15.6M3,455%
EBITDAN/AN/A-
Gain YTD-0.122-13.6141%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A133K-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SOLTF vs XTLB: Fundamental Ratings
SOLTF
XTLB
OUTLOOK RATING
1..100
504
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
47
Fair valued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
8798
PRICE GROWTH RATING
1..100
6142
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XTLB's Valuation (47) in the Biotechnology industry is somewhat better than the same rating for SOLTF (85) in the null industry. This means that XTLB’s stock grew somewhat faster than SOLTF’s over the last 12 months.

XTLB's Profit vs Risk Rating (92) in the Biotechnology industry is in the same range as SOLTF (100) in the null industry. This means that XTLB’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's SMR Rating (87) in the null industry is in the same range as XTLB (98) in the Biotechnology industry. This means that SOLTF’s stock grew similarly to XTLB’s over the last 12 months.

XTLB's Price Growth Rating (42) in the Biotechnology industry is in the same range as SOLTF (61) in the null industry. This means that XTLB’s stock grew similarly to SOLTF’s over the last 12 months.

XTLB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as SOLTF (100) in the null industry. This means that XTLB’s stock grew similarly to SOLTF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SOLTFXTLB
RSI
ODDS (%)
Bullish Trend 3 days ago
41%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
39%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
54%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
33%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
31%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
44%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bearish Trend 3 days ago
47%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIOKX46.350.27
+0.59%
Victory Pioneer R6
PLLAX26.360.12
+0.46%
Principal SmallCap A
JHAIX10.530.04
+0.38%
JHancock Multi-Asset Absolute Return I
RYCIX154.000.19
+0.12%
Rydex Consumer Products Inv
REINX17.06-0.05
-0.29%
Invesco Real Estate Investor

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
+0.82%
BIESF - SOLTF
35%
Loosely correlated
N/A
XTLB - SOLTF
24%
Poorly correlated
-2.51%
SPHRF - SOLTF
22%
Poorly correlated
N/A
PRTG - SOLTF
20%
Poorly correlated
-3.07%
SLNCF - SOLTF
9%
Poorly correlated
N/A
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been closely correlated with LABFF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if XTLB jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
-2.51%
LABFF - XTLB
70%
Closely correlated
N/A
SER - XTLB
59%
Loosely correlated
-2.35%
ENTBF - XTLB
29%
Poorly correlated
N/A
CLDI - XTLB
28%
Poorly correlated
-5.43%
ANRO - XTLB
27%
Poorly correlated
N/A
More